Oncologix Tech, Inc.
Oncologix Tech, Inc. (OCLG) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0000799694 · OCLG · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0000799694 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Oncologix Tech, Inc. (OTC: OCLG) has submitted 553 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2013. As a Financial Services sector company with CIK 0000799694, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Oncologix Tech, Inc.'s most comprehensive regulatory disclosure. The most recent Oncologix Tech, Inc. 10-K was filed on 2014-12-15 for fiscal year ending 2014. Historical OCLG 10-K annual reports are available from 1996 through 2014.
Investors researching Oncologix Tech, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
OCLG SEC Filings · 8 questionsOncologix Tech, Inc. (OCLG) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 553 filings and access original documents at no cost. Oncologix Tech, Inc.'s CIK is 0000799694.